Updates in management of acute invasive fungal rhinosinusitis
Related Experiment Video
Updated: Jan 31, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
1Department of Otolaryngology-Head and Neck Surgery, Henry Ford Health System, Grand Blvd, Detroit, Michigan, USA.
Purpose Of Review:
Acute invasive fungal rhinosinusitis (AIFRS) is a rare and often fatal disease, that remains incompletely understood. Case series and literature reviews constitute most of the literature on AIFRS, and act as the standards by which we treat these extremely complex patients. This review discusses management of AIFRS, with focuses on optimal diagnostic and therapeutic strategies.
Recent Findings:
Mortality rates remain high, around 50% overall, though some recent studies have shown higher survival rates with early diagnosis and complete surgical resection. Some recent publications on AIFRS have focused on the utility of frozen section analysis both to diagnose and potentially guide the completeness of endoscopic surgical debridement. It was also recently shown that complete endoscopic resection of disease leads to higher survival than when disease was incompletely resected. Additionally, a new antifungal agent was recently approved by the FDA, which has a more favorable pharmacologic and side effect profile, though more studies are necessary to determine its utility.
Summary:
Early diagnosis requires identification of sinusitis symptoms in immunocompromised patients, followed by intranasal biopsy and frozen section analysis. Early surgical debridement and antifungal therapy then remain the cornerstones of AIFRS management.
Video Abstract:
See Video, Supplemental Digital Content 1, http://links.lww.com/COOH/A38.
Insights
Early diagnosis and treatment are crucial for improving survival rates in acute invasive fungal rhinosinusitis (AIFRS). Prompt surgical debridement and antifungal therapy are key management strategies for this rare, often fatal condition.
Area of Science:
- Otolaryngology
- Infectious Diseases
- Pathology
Background:
- Acute invasive fungal rhinosinusitis (AIFRS) is a rare, severe, and often fatal condition with limited understanding.
- Current literature primarily consists of case series and reviews, guiding treatment for complex patients.
Purpose of the Study:
- To review and discuss optimal diagnostic and therapeutic strategies for managing AIFRS.
- To highlight recent advancements in the diagnosis and treatment of AIFRS.
Main Methods:
- Literature review focusing on diagnostic and therapeutic approaches for AIFRS.
- Analysis of recent studies on frozen section analysis and surgical resection outcomes.
- Evaluation of new antifungal agents.
Main Results:
- Mortality for AIFRS remains high (around 50%), but early diagnosis and complete surgical resection show improved survival.
- Frozen section analysis is valuable for diagnosing AIFRS and assessing surgical resection completeness.
- A new FDA-approved antifungal agent offers a favorable profile, pending further study.
Conclusions:
- Early AIFRS diagnosis involves recognizing sinusitis symptoms in immunocompromised individuals, followed by intranasal biopsy and frozen section analysis.
- Cornerstones of AIFRS management include early surgical debridement and prompt antifungal therapy.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Coronary Syndrome V: Nursing Management
Acute Kidney Injury VI: Nursing Management
Fungal Group Zygomycota
Fungal Phylum Microsporidia

